Literature DB >> 11239880

Indocyanine green selectively stains the internal limiting membrane.

A Gandorfer1, E M Messmer, M W Ulbig, A Kampik.   

Abstract

PURPOSE: To demonstrate whether indocyanine green stains the inner limiting membrane of the retina or residual vitreous cortex.
METHODS: We report on the intraoperative staining patterns of the vitreomacular interface in 10 eyes of 10 consecutive patients who underwent vitrectomy with indocyanine green staining for macular hole formation and diffuse diabetic macular edema.
RESULTS: In five eyes of five patients with macular holes, indocyanine green staining of the macula after posterior vitreous detachment resulted in an immediate visibility of a discernable membrane that was not previously seen. In five eyes of five patients with diffuse diabetic macular edema and adherent cortical vitreous, indocyanine green failed to stain the vitreomacular interface. After peeling off the residual vitreous cortex, however, a discernable membrane could be identified using indocyanine green dye again. Light and transmission electron microscopy revealed the inner limiting membrane as the membrane that had been stained and removed in all specimens.
CONCLUSION: Indocyanine green selectively stains the inner limiting membrane. Staining of the vitreomacular interface using indocyanine green as a vital dye enables the surgeon to distinguish between the residual vitreous cortex and the inner limiting membrane, and it allows safer and easier removal of the inner limiting membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239880     DOI: 10.1016/s0002-9394(00)00924-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  35 in total

1.  Sub-retinal hemorrhage during internal limiting membrane peeling for a macular hole.

Authors:  Ko Nakata; Masahito Ohji; Yasushi Ikuno; Shunji Kusaka; Fumi Gomi; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-09       Impact factor: 3.117

2.  Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference?

Authors:  Kelvin Rivett; Louis Kruger; Sarah Radloff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-29       Impact factor: 3.117

3.  Epiretinal pathology of vitreomacular traction syndrome.

Authors:  A Gandorfer; M Rohleder; A Kampik
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

Review 4.  [Surgery for macular edema].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

5.  [Retinal ICG-accumulation after ILM-staining during macular hole surgery?].

Authors:  I Krömer; A Lommatzsch; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

6.  Which colour suits the vitreoretinal surgeon?

Authors:  Nanny Collaer; Peter Stalmans
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

7.  Photothermal optical coherence tomography of indocyanine green in ex vivo eyes.

Authors:  Maryse Lapierre-Landry; Thomas B Connor; Joseph Carroll; Yuankai K Tao; Melissa C Skala
Journal:  Opt Lett       Date:  2018-06-01       Impact factor: 3.776

8.  Changes in visual field defects during 10-year follow-up for indocyanine green-assisted macular hole surgery.

Authors:  Masanori Nakazawa; Hiroto Terasaki; Takehiro Yamashita; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2016-06-07       Impact factor: 2.447

9.  Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.

Authors:  Shigeki Machida; Yoshiharu Toba; Tomoharu Nishimura; Takayuki Ohzeki; Ken-ichi Murai; Daijiro Kurosaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-02       Impact factor: 3.117

10.  Does intravitreal triamcinolone acetonide-assisted peeling of the internal limiting membrane effect the outcome of macular hole surgery?

Authors:  Murat Karacorlu; Hakan Ozdemir; Serra Arf Karacorlu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.